These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35428209)

  • 1. Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018.
    Domínguez-Domínguez L; Rava M; Bisbal O; Lopez-Cortés L; Portilla J; Podzamczer D; Olalla J; Fuster D; Rubio R; Jarrín I; Iribarren JA; Moreno S;
    BMC Infect Dis; 2022 Apr; 22(1):379. PubMed ID: 35428209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late presentations and missed opportunities among newly diagnosed HIV patients presenting to a specialty clinic in Lebanon.
    Mahmoud M; Ballouz T; Lahoud C; Adnan J; Habib PA; Saab R; Farhat H; Hussein ME; Rizk N
    Sci Rep; 2024 Apr; 14(1):8296. PubMed ID: 38594292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events.
    Martínez-Sanz J; Díaz-Álvarez J; Rosas M; Ron R; Iribarren JA; Bernal E; Gutiérrez F; Ruiz Sancho A; Cabello N; Olalla J; Moreno S; Serrano-Villar S;
    EBioMedicine; 2023 Sep; 95():104773. PubMed ID: 37639938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events.
    Serrano-Villar S; Wu K; Hunt PW; Lok JJ; Ron R; Sainz T; Moreno S; Deeks SG; Bosch RJ
    EBioMedicine; 2022 Jun; 80():104072. PubMed ID: 35644125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
    Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4/CD8 ratio normalization rates and low ratio as prognostic marker for non-AIDS defining events among long-term virologically suppressed people living with HIV.
    Han WM; Apornpong T; Kerr SJ; Hiransuthikul A; Gatechompol S; Do T; Ruxrungtham K; Avihingsanon A
    AIDS Res Ther; 2018 Sep; 15(1):13. PubMed ID: 30261902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
    Rava M; Bisbal O; Domínguez-Domínguez L; Aleman MR; Rivero M; Antela A; Estrada V; Ribera E; Muñoz A; Iribarren JA; Moreno S; Rubio R; Jarrín I;
    AIDS; 2021 Jul; 35(8):1283-1293. PubMed ID: 33813554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
    Serrano-Villar S; Martínez-Sanz J; Ron R; Talavera-Rodríguez A; Fernández-Felix BM; Herrera S; Muriel A; Fanjul F; Portilla J; Muñoz J; Amador C; de Zárraga MA; Vivancos MJ; Moreno S;
    Lancet HIV; 2020 Aug; 7(8):e565-e573. PubMed ID: 32763219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort.
    Raffetti E; Postorino MC; Castelli F; Casari S; Castelnuovo F; Maggiolo F; Di Filippo E; D'Avino A; Gori A; Ladisa N; Di Pietro M; Sighinolfi L; Zacchi F; Torti C
    BMC Public Health; 2016 Aug; 16(1):878. PubMed ID: 27557878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late presentation among patients with human immunodeficiency virus infection in Turkey.
    Karaosmanoğlu HK; Mete B; Gündüz A; Aydin ÖA; Sargin F; Sevgi DY; Durdu B; Dökmetaş İ; Tabak F
    Cent Eur J Public Health; 2019 Sep; 27(3):229-234. PubMed ID: 31580559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy.
    Okhai H; Vivancos-Gallego MJ; Hill T; Sabin CA
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):808-816. PubMed ID: 32664736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters.
    Iannetta M; Savinelli S; Rossi R; Mascia C; Marocco R; Vita S; Zuccalà P; Zingaropoli MA; Mengoni F; Massetti AP; Falciano M; d'Ettorre G; Ciardi MR; Mastroianni CM; Vullo V; Lichtner M
    Immunobiology; 2019 Mar; 224(2):231-241. PubMed ID: 30522891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana.
    Martinez SS; Campa A; Bussmann H; Moyo S; Makhema J; Huffman FG; Williams OD; Essex M; Marlink R; Baum MK
    Br J Nutr; 2016 Jun; 115(12):2114-21. PubMed ID: 27087233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.
    Serrano-Villar S; Sainz T; Lee SA; Hunt PW; Sinclair E; Shacklett BL; Ferre AL; Hayes TL; Somsouk M; Hsue PY; Van Natta ML; Meinert CL; Lederman MM; Hatano H; Jain V; Huang Y; Hecht FM; Martin JN; McCune JM; Moreno S; Deeks SG
    PLoS Pathog; 2014 May; 10(5):e1004078. PubMed ID: 24831517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study.
    Mussini C; Lorenzini P; Cozzi-Lepri A; Lapadula G; Marchetti G; Nicastri E; Cingolani A; Lichtner M; Antinori A; Gori A; d'Arminio Monforte A;
    Lancet HIV; 2015 Mar; 2(3):e98-106. PubMed ID: 26424550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent poor clinical outcomes of people living with HIV presenting with AIDS and late HIV diagnosis - results from the ICONA cohort in Italy, 2009-2022.
    Mondi A; Cozzi-Lepri A; Tavelli A; Cingolani A; Giacomelli A; Orofino G; De Girolamo G; Pinnetti C; Gori A; Saracino A; Bandera A; Marchetti G; Girardi E; Mussini C; d'Arminio Monforte A; Antinori A;
    Int J Infect Dis; 2024 May; 142():106995. PubMed ID: 38458423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
    Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
    Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily.
    Celesia BM; Castronuovo D; Pinzone MR; Bellissimo F; Mughini MT; Lupo G; Scarpino MR; Gussio M; Palermo F; Cosentino S; Cacopardo B; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2218-24. PubMed ID: 23893189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.